Anebulo Pharmaceuticals Total Liabilities

Anebulo Pharmaceuticals (ANEB) currently reports a total liabilities of $1.5M as of December 2025. That compares with $880K in the prior-year period — up 69.1% year over year. Use the charts on this page to explore Anebulo Pharmaceuticals's total liabilities history and peer comparisons.

Anebulo Pharmaceuticals's total liabilities increased from $880K to $1.5M — a 69.1% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anebulo Pharmaceuticals reported $1.5M in total liabilities as of December 2025. That compares with $880K in the prior-year period — up 69.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $1.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anebulo Pharmaceuticals, and consider following ANEB for alerts when major investors trade the stock.

Anebulo Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $1.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ANEB with unrelated industries.